Importation Of Chinese-authorized Ifosfamide For Injection Due To The Current Shortage Of Canadian-authorized Ifex (ifosfamide For Injection)
Recall Summary Health Canada authorized a temporary importation of Chinese-manufactured Ifosfamide for Injection to address a shortage of the Canadian-authorized version (IFEX) used in cancer treatment. This product is distributed across Canada. The authorization addresses supply issues and labelling differences between the imported and standard Canadian product.
- Product
- Ifosfamide for Injection, 1 g per vial
- Reason
- Product safety - Supply - Labelling
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-06-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/87dd8bdf-1937-4070-b6c1-f0baf2592d51